AQR Capital Management’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-52,835
Closed -$1.18M 2799
2024
Q2
$1.18M Buy
52,835
+30,784
+140% +$687K ﹤0.01% 1680
2024
Q1
$1.3M Sell
22,051
-24,559
-53% -$1.44M ﹤0.01% 1586
2023
Q4
$1.03M Buy
46,610
+12,059
+35% +$267K ﹤0.01% 1595
2023
Q3
$745K Buy
34,551
+31,355
+981% +$676K ﹤0.01% 1714
2023
Q2
$216K Buy
3,196
+2,517
+371% +$170K ﹤0.01% 2066
2023
Q1
$317K Buy
+679
New +$317K ﹤0.01% 1927
2022
Q4
Sell
-1,611
Closed -$524K 2226
2022
Q3
$524K Buy
+1,611
New +$524K ﹤0.01% 1765
2022
Q2
Sell
-3,011
Closed -$905K 2219
2022
Q1
$905K Buy
+3,011
New +$905K ﹤0.01% 1590
2021
Q4
Sell
-3,083
Closed -$788K 2223
2021
Q3
$788K Buy
+3,083
New +$788K ﹤0.01% 1664
2021
Q1
Sell
-343
Closed -$318K 2217
2020
Q4
$318K Sell
343
-238
-41% -$221K ﹤0.01% 1948
2020
Q3
$597K Sell
581
-1,564
-73% -$1.61M ﹤0.01% 1645
2020
Q2
$2.17M Sell
2,145
-785
-27% -$795K ﹤0.01% 1121
2020
Q1
$2.55M Sell
2,930
-950
-24% -$825K ﹤0.01% 990
2019
Q4
$4.16M Buy
3,880
+3,217
+485% +$3.45M ﹤0.01% 1029
2019
Q3
$613K Sell
663
-13
-2% -$12K ﹤0.01% 1680
2019
Q2
$764K Buy
676
+437
+183% +$494K ﹤0.01% 1588
2019
Q1
$325K Sell
239
-80
-25% -$109K ﹤0.01% 1942
2018
Q4
$369K Sell
319
-1,454
-82% -$1.68M ﹤0.01% 1887
2018
Q3
$2.69M Sell
1,773
-895
-34% -$1.36M ﹤0.01% 1263
2018
Q2
$4.18M Sell
2,668
-2,425
-48% -$3.8M ﹤0.01% 1105
2018
Q1
$5.88M Sell
5,093
-1,631
-24% -$1.88M 0.01% 939
2017
Q4
$7.97M Buy
6,724
+388
+6% +$460K 0.01% 857
2017
Q3
$8.52M Buy
6,336
+5,160
+439% +$6.94M 0.01% 838
2017
Q2
$950K Buy
+1,176
New +$950K ﹤0.01% 1690